Repligen
RGEN
444 hedge funds and large institutions have $8.24B invested in Repligen in 2024 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 157 increasing their positions, 158 reducing their positions, and 81 closing their positions.
34% more call options, than puts
Call options by funds: $55M | Put options by funds: $40.9M
17% more capital invested
Capital invested by funds: $7.06B → $8.24B (+$1.18B)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 158
1.26% less ownership
Funds ownership: 100.26% → 99.01% (-1.3%)
2% less funds holding
Funds holding: 455 → 444 (-11)
11% less first-time investments, than exits
New positions opened: 72 | Existing positions closed: 81
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$256M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$122M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$73.5M |
| 4 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$40.6M |
| 5 |
Two Sigma Investments
New York
|
+$32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$98.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$92M |
| 3 |
Millennium Management
New York
|
-$91.3M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$69.2M |
| 5 |
BlackRock
New York
|
-$66.1M |
RGEN Hedge Fund Activity: Q3 2024 in Review
444 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q3 2024, worth a combined $8.24B — up 17% from $7.06B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of RGEN and 72 opened new positions — a net loss of 9 holders — while 158 trimmed existing stakes and 157 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $256M. The largest seller was Wellington Management Group, exiting entirely with an estimated $98.8M sold.
- 444 institutional investors held Repligen (RGEN) as of Q3 2024, down from 455 in Q2 2024.
- Funds reported $8.24B of Repligen stock for Q3 2024, up 17% quarter-over-quarter.
- 72 funds opened new Repligen positions in Q3 2024 and 81 closed out, a net change of -9 holders.
- The largest Repligen buyer in Q3 2024 was T. Rowe Price Associates, an estimated $256M added.
- The largest Repligen seller in Q3 2024 was Wellington Management Group, an estimated $98.8M sold.
Based on aggregated 13F filings for Q3 2024.